Quoin Pharmaceuticals, Ltd.
- QNRX
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Netherton Syndrome Treatment
$3.90
Today −3.23%Quote Oct 16, 2026, 08:00 PM UTC
−44.37%over the last month
Max drawdown −44.8%From 1-month high −44.8%3 months −7.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$274.1M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$17.00
+335.9% from here
Floor
$3.58
8.3% below price
Where the price sits
4 analysts
Analyst range, low to high
$14.00$20.00
- Price $3.90
- Resistance $3.91
- Consensus $17.00
The price is right under resistance. Analysts' average target sits about 336% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about QNRXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
4